Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11753443 Conjugated hepcidin mimetics

Patent 11753443 was granted and assigned to Protagonist Therapeutics on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 13 Sep, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 13 Sep, 2023
Edits made to:
Infobox (+55 properties)
Article (+151 characters)
‌

 US Patent 11753443 Conjugated hepcidin mimetics

Article

The present invention provides hepcidin analogues with improved in vivo half lives, and related pharmaceutical compositions and methods of use thereof.

Infobox
Is a
Patent
Patent
Patent Applicant
Protagonist Therapeutics
Protagonist Therapeutics
Current Assignee
Protagonist Therapeutics
Protagonist Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11753443
Patent Inventor Names
Adam Stephenson
Ashok Bhandari
Brian Troy Frederick
David Liu
Gregory Thomas Bourne
Jie Zhang
Mark Leslie Smythe
Roopa Taranath
Date of Patent
September 12, 2023
Patent Application Number
16964708
Date Filed
February 8, 2019
Patent Citations
‌
US Patent 11111272 α4α7 peptide monomer and dimer antagonists
‌
US Patent 7534764 Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
‌
US Patent 7589170 Synthesis of cyclic peptides
‌
US Patent 7718598 Auxiliary for amide bond formation
‌
US Patent 7745391 Human thrombospondin polypeptide
‌
US Patent 8313950 Hepcidins as biomarkers for impending lupus nephritis flare
‌
US Patent 8435941 Mini-hepcidin peptides and methods of using thereof
‌
US Patent 8536140 Methods for treating inflammatory bowel disease
‌
US Patent 8568706 Modified human interferon-beta polypeptides
‌
US Patent 8796418 Stabilized alpha helical peptides and uses thereof
‌
US Patent 8946150 Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
‌
US Patent 8999935 Treatment of osteoporosis in peri- and post-menopausal women with hepcidin
‌
US Patent 9169292 Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
‌
US Patent 9273093 α4β7 peptide dimer antagonists
‌
US Patent 9315545 Hepcidin mimetic peptides and uses thereof
‌
US Patent 9518091 A4B7 peptide monomer and dimer antagonists
‌
US Patent 9624268 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
‌
US Patent 9714270 a4B7 integrin thioether peptide antagonists
‌
US Patent 9809623 α4β7 peptide monomer and dimer antagonists
‌
US Patent 9822157 Hepcidin analogues and uses thereof
‌
US Patent 10023614 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
‌
US Patent 10030061 Hepcidin analogues and uses thereof
‌
US Patent 10035824 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
‌
US Patent 10059744 α4β7 thioether peptide dimer antagonists
‌
US Patent 10196424 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
‌
US Patent 10278957 Opioid agonist peptides and uses thereof
‌
US Patent 10301371 Cyclic monomer and dimer peptides having integrin antagonist activity
‌
US Patent 10407468 Methods for synthesizing α4β7 peptide antagonists
‌
US Patent 10442846 Hepcidin analogues and uses thereof
‌
US Patent 10501515 Hepcidin analogues and uses thereof
‌
US Patent 10626146 α4β7 thioether peptide dimer antagonists
‌
US Patent 10729676 Opioid agonist peptides and uses thereof
‌
US Patent 10787490 Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
‌
US Patent 10941183 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
‌
US Patent 11041000 Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
‌
US Patent 11472842 Analogues of hepcidin mimetics with improved in vivo half lives
Patent Primary Examiner
‌
Amber D Steele
CPC Code
‌
C07K 7/08
‌
A61K 38/00

Find more entities like US Patent 11753443 Conjugated hepcidin mimetics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.